nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—CYP1A2—chronic obstructive pulmonary disease	0.708	1	CbGaD
Carmustine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0167	1	CbGbCtD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD3—chronic obstructive pulmonary disease	0.00824	0.0909	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.00757	0.0836	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GCLC—chronic obstructive pulmonary disease	0.0061	0.0673	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.00494	0.0545	CbGpPWpGaD
Carmustine—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00394	0.0435	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GSTM1—chronic obstructive pulmonary disease	0.00393	0.0434	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GSTP1—chronic obstructive pulmonary disease	0.00377	0.0415	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.00341	0.0377	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.0032	0.0353	CbGpPWpGaD
Carmustine—GSR—respiratory system—chronic obstructive pulmonary disease	0.00312	0.223	CbGeAlD
Carmustine—GSR—Oxidative Stress—CYP1A1—chronic obstructive pulmonary disease	0.00302	0.0333	CbGpPWpGaD
Carmustine—GSR—connective tissue—chronic obstructive pulmonary disease	0.00274	0.196	CbGeAlD
Carmustine—GSR—bronchus—chronic obstructive pulmonary disease	0.00257	0.183	CbGeAlD
Carmustine—GSR—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00244	0.0269	CbGpPWpGaD
Carmustine—GSR—trachea—chronic obstructive pulmonary disease	0.0023	0.164	CbGeAlD
Carmustine—GSR—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00215	0.0237	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00214	0.0236	CbGpPWpGaD
Carmustine—GSR—lung—chronic obstructive pulmonary disease	0.00166	0.118	CbGeAlD
Carmustine—GSR—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00152	0.0168	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00139	0.0154	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.00133	0.0147	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00132	0.0146	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00129	0.0143	CbGpPWpGaD
Carmustine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00125	0.0138	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00113	0.0125	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00107	0.0118	CbGpPWpGaD
Carmustine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00106	0.0757	CbGeAlD
Carmustine—GSR—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.0112	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000976	0.0108	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000972	0.0107	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000962	0.0106	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000897	0.00989	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000868	0.00958	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000866	0.00956	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000844	0.00931	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000776	0.00856	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000735	0.00811	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000724	0.00799	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000705	0.00778	CbGpPWpGaD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000614	0.00677	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000608	0.0067	CbGpPWpGaD
Carmustine—GSR—Metabolism—APIP—chronic obstructive pulmonary disease	0.0006	0.00662	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000589	0.0065	CbGpPWpGaD
Carmustine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000563	0.0402	CbGeAlD
Carmustine—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000558	0.00616	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000513	0.00566	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000512	0.00565	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000494	0.00545	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000432	0.00476	CbGpPWpGaD
Carmustine—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000418	0.00245	CcSEcCtD
Carmustine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000415	0.00243	CcSEcCtD
Carmustine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.00243	CcSEcCtD
Carmustine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000413	0.00242	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000413	0.00456	CbGpPWpGaD
Carmustine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000413	0.00242	CcSEcCtD
Carmustine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00041	0.0024	CcSEcCtD
Carmustine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000409	0.0024	CcSEcCtD
Carmustine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00239	CcSEcCtD
Carmustine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000407	0.00239	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000407	0.00449	CbGpPWpGaD
Carmustine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.00238	CcSEcCtD
Carmustine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00238	CcSEcCtD
Carmustine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00238	CcSEcCtD
Carmustine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00238	CcSEcCtD
Carmustine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000405	0.00237	CcSEcCtD
Carmustine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00237	CcSEcCtD
Carmustine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00237	CcSEcCtD
Carmustine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00234	CcSEcCtD
Carmustine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00233	CcSEcCtD
Carmustine—GSR—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000397	0.00438	CbGpPWpGaD
Carmustine—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.00232	CcSEcCtD
Carmustine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.0023	CcSEcCtD
Carmustine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00229	CcSEcCtD
Carmustine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000391	0.00229	CcSEcCtD
Carmustine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.00229	CcSEcCtD
Carmustine—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00227	CcSEcCtD
Carmustine—GSR—Metabolism—GC—chronic obstructive pulmonary disease	0.000387	0.00427	CbGpPWpGaD
Carmustine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000386	0.00226	CcSEcCtD
Carmustine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00225	CcSEcCtD
Carmustine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00224	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000381	0.00421	CbGpPWpGaD
Carmustine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00222	CcSEcCtD
Carmustine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00222	CcSEcCtD
Carmustine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.00221	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000372	0.00218	CcSEcCtD
Carmustine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00218	CcSEcCtD
Carmustine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00218	CcSEcCtD
Carmustine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000371	0.00217	CcSEcCtD
Carmustine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00217	CcSEcCtD
Carmustine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00216	CcSEcCtD
Carmustine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00215	CcSEcCtD
Carmustine—GSR—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000366	0.00403	CbGpPWpGaD
Carmustine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00213	CcSEcCtD
Carmustine—GSR—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000359	0.00397	CbGpPWpGaD
Carmustine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00209	CcSEcCtD
Carmustine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000354	0.00208	CcSEcCtD
Carmustine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00207	CcSEcCtD
Carmustine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00205	CcSEcCtD
Carmustine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00205	CcSEcCtD
Carmustine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00204	CcSEcCtD
Carmustine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00204	CcSEcCtD
Carmustine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00204	CcSEcCtD
Carmustine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00202	CcSEcCtD
Carmustine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00202	CcSEcCtD
Carmustine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00202	CcSEcCtD
Carmustine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00202	CcSEcCtD
Carmustine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000343	0.00201	CcSEcCtD
Carmustine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00201	CcSEcCtD
Carmustine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00201	CcSEcCtD
Carmustine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00201	CcSEcCtD
Carmustine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00201	CcSEcCtD
Carmustine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000341	0.002	CcSEcCtD
Carmustine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00197	CcSEcCtD
Carmustine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00197	CcSEcCtD
Carmustine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000334	0.00196	CcSEcCtD
Carmustine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00193	CcSEcCtD
Carmustine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00193	CcSEcCtD
Carmustine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00193	CcSEcCtD
Carmustine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00192	CcSEcCtD
Carmustine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00192	CcSEcCtD
Carmustine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.0019	CcSEcCtD
Carmustine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.0019	CcSEcCtD
Carmustine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.0019	CcSEcCtD
Carmustine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00189	CcSEcCtD
Carmustine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00189	CcSEcCtD
Carmustine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00189	CcSEcCtD
Carmustine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00189	CcSEcCtD
Carmustine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00188	CcSEcCtD
Carmustine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00188	CcSEcCtD
Carmustine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.00187	CcSEcCtD
Carmustine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00185	CcSEcCtD
Carmustine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00185	CcSEcCtD
Carmustine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00182	CcSEcCtD
Carmustine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00181	CcSEcCtD
Carmustine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.00181	CcSEcCtD
Carmustine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000308	0.00181	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000305	0.00337	CbGpPWpGaD
Carmustine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00179	CcSEcCtD
Carmustine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00178	CcSEcCtD
Carmustine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000303	0.00178	CcSEcCtD
Carmustine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.00176	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00176	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00176	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.0003	0.00331	CbGpPWpGaD
Carmustine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00175	CcSEcCtD
Carmustine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00175	CcSEcCtD
Carmustine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00174	CcSEcCtD
Carmustine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00174	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000294	0.00172	CcSEcCtD
Carmustine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00172	CcSEcCtD
Carmustine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00172	CcSEcCtD
Carmustine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00172	CcSEcCtD
Carmustine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00172	CcSEcCtD
Carmustine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00171	CcSEcCtD
Carmustine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00171	CcSEcCtD
Carmustine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00029	0.0017	CcSEcCtD
Carmustine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00168	CcSEcCtD
Carmustine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00168	CcSEcCtD
Carmustine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00168	CcSEcCtD
Carmustine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00167	CcSEcCtD
Carmustine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00167	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00166	CcSEcCtD
Carmustine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00165	CcSEcCtD
Carmustine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00165	CcSEcCtD
Carmustine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00165	CcSEcCtD
Carmustine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00165	CcSEcCtD
Carmustine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00165	CcSEcCtD
Carmustine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00165	CcSEcCtD
Carmustine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00164	CcSEcCtD
Carmustine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00163	CcSEcCtD
Carmustine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00163	CcSEcCtD
Carmustine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00162	CcSEcCtD
Carmustine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00162	CcSEcCtD
Carmustine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.00161	CcSEcCtD
Carmustine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00161	CcSEcCtD
Carmustine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.0016	CcSEcCtD
Carmustine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.0016	CcSEcCtD
Carmustine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00159	CcSEcCtD
Carmustine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00159	CcSEcCtD
Carmustine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00159	CcSEcCtD
Carmustine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00159	CcSEcCtD
Carmustine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00158	CcSEcCtD
Carmustine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00158	CcSEcCtD
Carmustine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00158	CcSEcCtD
Carmustine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00158	CcSEcCtD
Carmustine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00156	CcSEcCtD
Carmustine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00156	CcSEcCtD
Carmustine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00155	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00155	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00291	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00291	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00291	CbGpPWpGaD
Carmustine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00153	CcSEcCtD
Carmustine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00153	CcSEcCtD
Carmustine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00153	CcSEcCtD
Carmustine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00153	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00026	0.00287	CbGpPWpGaD
Carmustine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00152	CcSEcCtD
Carmustine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.00151	CcSEcCtD
Carmustine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00151	CcSEcCtD
Carmustine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00151	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000257	0.00283	CbGpPWpGaD
Carmustine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.0015	CcSEcCtD
Carmustine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.0015	CcSEcCtD
Carmustine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000255	0.0015	CcSEcCtD
Carmustine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000255	0.0015	CcSEcCtD
Carmustine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00149	CcSEcCtD
Carmustine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00149	CcSEcCtD
Carmustine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00148	CcSEcCtD
Carmustine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00147	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000248	0.00274	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00272	CbGpPWpGaD
Carmustine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00144	CcSEcCtD
Carmustine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00144	CcSEcCtD
Carmustine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00142	CcSEcCtD
Carmustine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00142	CcSEcCtD
Carmustine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00142	CcSEcCtD
Carmustine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.00142	CcSEcCtD
Carmustine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00141	CcSEcCtD
Carmustine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00139	CcSEcCtD
Carmustine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00139	CcSEcCtD
Carmustine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00139	CcSEcCtD
Carmustine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00136	CcSEcCtD
Carmustine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00136	CcSEcCtD
Carmustine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00134	CcSEcCtD
Carmustine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00132	CcSEcCtD
Carmustine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00132	CcSEcCtD
Carmustine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00132	CcSEcCtD
Carmustine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00131	CcSEcCtD
Carmustine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000221	0.0013	CcSEcCtD
Carmustine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00128	CcSEcCtD
Carmustine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00128	CcSEcCtD
Carmustine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00128	CcSEcCtD
Carmustine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00125	CcSEcCtD
Carmustine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00125	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00235	CbGpPWpGaD
Carmustine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00125	CcSEcCtD
Carmustine—GSR—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000211	0.00233	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00232	CbGpPWpGaD
Carmustine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00123	CcSEcCtD
Carmustine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00123	CcSEcCtD
Carmustine—GSR—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000209	0.0023	CbGpPWpGaD
Carmustine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00122	CcSEcCtD
Carmustine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00122	CcSEcCtD
Carmustine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00122	CcSEcCtD
Carmustine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00122	CcSEcCtD
Carmustine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00121	CcSEcCtD
Carmustine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00121	CcSEcCtD
Carmustine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00121	CcSEcCtD
Carmustine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00121	CcSEcCtD
Carmustine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00121	CcSEcCtD
Carmustine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000205	0.0012	CcSEcCtD
Carmustine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00119	CcSEcCtD
Carmustine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00119	CcSEcCtD
Carmustine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00119	CcSEcCtD
Carmustine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00119	CcSEcCtD
Carmustine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00117	CcSEcCtD
Carmustine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00116	CcSEcCtD
Carmustine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00115	CcSEcCtD
Carmustine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00115	CcSEcCtD
Carmustine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00115	CcSEcCtD
Carmustine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00115	CcSEcCtD
Carmustine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00114	CcSEcCtD
Carmustine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00112	CcSEcCtD
Carmustine—GSR—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00019	0.0021	CbGpPWpGaD
Carmustine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00111	CcSEcCtD
Carmustine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00111	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	0.000187	0.00207	CbGpPWpGaD
Carmustine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00108	CcSEcCtD
Carmustine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00108	CcSEcCtD
Carmustine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00107	CcSEcCtD
Carmustine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00107	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00018	0.00199	CbGpPWpGaD
Carmustine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00105	CcSEcCtD
Carmustine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00105	CcSEcCtD
Carmustine—GSR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00194	CbGpPWpGaD
Carmustine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00102	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00191	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	0.000171	0.00189	CbGpPWpGaD
Carmustine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000171	0.001	CcSEcCtD
Carmustine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000994	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000165	0.00183	CbGpPWpGaD
Carmustine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000956	CcSEcCtD
Carmustine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000947	CcSEcCtD
Carmustine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000946	CcSEcCtD
Carmustine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00094	CcSEcCtD
Carmustine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000938	CcSEcCtD
Carmustine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000932	CcSEcCtD
Carmustine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000932	CcSEcCtD
Carmustine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000895	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000152	0.00168	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00015	0.00166	CbGpPWpGaD
Carmustine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000878	CcSEcCtD
Carmustine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000863	CcSEcCtD
Carmustine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000861	CcSEcCtD
Carmustine—GSR—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000146	0.00162	CbGpPWpGaD
Carmustine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000856	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000146	0.00161	CbGpPWpGaD
Carmustine—GSR—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000144	0.00159	CbGpPWpGaD
Carmustine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000807	CcSEcCtD
Carmustine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000805	CcSEcCtD
Carmustine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000793	CcSEcCtD
Carmustine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000791	CcSEcCtD
Carmustine—GSR—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000135	0.00148	CbGpPWpGaD
Carmustine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000771	CcSEcCtD
Carmustine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000761	CcSEcCtD
Carmustine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000756	CcSEcCtD
Carmustine—GSR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00141	CbGpPWpGaD
Carmustine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000742	CcSEcCtD
Carmustine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000725	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000123	0.00136	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000693	CcSEcCtD
Carmustine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000692	CcSEcCtD
Carmustine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000688	CcSEcCtD
Carmustine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000683	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000113	0.00125	CbGpPWpGaD
Carmustine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000661	CcSEcCtD
Carmustine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00066	CcSEcCtD
Carmustine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000659	CcSEcCtD
Carmustine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000656	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000111	0.00123	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000111	0.00123	CbGpPWpGaD
Carmustine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00065	CcSEcCtD
Carmustine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000627	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000107	0.00118	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000622	CcSEcCtD
Carmustine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000622	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000106	0.00117	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000106	0.00117	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000105	0.00116	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00115	CbGpPWpGaD
Carmustine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000601	CcSEcCtD
Carmustine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000601	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.68e-05	0.00107	CbGpPWpGaD
Carmustine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.00056	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.55e-05	0.00105	CbGpPWpGaD
Carmustine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000546	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.18e-05	0.00101	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.05e-05	0.000999	CbGpPWpGaD
Carmustine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.00052	CcSEcCtD
Carmustine—GSR—Metabolism—ALB—chronic obstructive pulmonary disease	8.67e-05	0.000956	CbGpPWpGaD
Carmustine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000503	CcSEcCtD
Carmustine—GSR—Metabolism—NOS3—chronic obstructive pulmonary disease	8.29e-05	0.000915	CbGpPWpGaD
Carmustine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000484	CcSEcCtD
Carmustine—Rash—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.00048	CcSEcCtD
Carmustine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000479	CcSEcCtD
Carmustine—Headache—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000476	CcSEcCtD
Carmustine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000452	CcSEcCtD
Carmustine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	7.38e-05	0.000815	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.26e-05	0.000581	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.89e-05	0.00054	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	4.76e-05	0.000525	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.42e-05	0.000488	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.000389	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.6e-05	0.000287	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.57e-05	0.000283	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.4e-05	0.000264	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.000259	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.8e-05	0.000199	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.78e-05	0.000196	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.000183	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.000173	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	0.000118	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000113	CbGpPWpGaD
